IGM Biosciences (IGMS)
(Real Time Quote from BATS)
$10.00 USD
+0.37 (3.84%)
Updated May 1, 2024 09:48 AM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IGMS 10.00 +0.37(3.84%)
Will IGMS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IGMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IGMS
IGM Biosciences (IGMS) Upgraded to Buy: What Does It Mean for the Stock?
Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings
IGMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
Wall Street Analysts Think IGM Biosciences, Inc. (IGMS) Could Surge 63.1%: Read This Before Placing a Bet
Other News for IGMS
Analysts’ Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)
Stifel Nicolaus Sticks to Its Buy Rating for IGM Biosciences (IGMS)
IGM Biosciences weakness creates 'interesting opportunity,' says Stifel
What 5 Analyst Ratings Have To Say About IGM Biosciences
IGM Biosciences Announces Refocusing of Sanofi Collaboration